Most large, clinical trials of vitamin supplements, including some that have concluded they are of no value or even harmful, have a flawed methodology that renders them largely useless in determining the real value of these micronutrients, ...
Tags: vitamin supplements, flawed methodology, micronutrients
Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States (U.S.) Food & Drug Administration (FDA) has extended the Prescription Drug User ...
Tags: Takeda Pharmaceutical Company Limited, Prescription Drug User Fee Act
Prescription-drug abuse likely isn't on your mind when you open your home to holiday guests. But it's amajor problem in the United States, and you should take preventive action when hosting a party, experts say. "We don't like to think of ...
Tags: Health, Medicine, Prescription-drug, drug
Oxycodone -- the active ingredient in OxyContin -- and hydrocodone are the most popular drugs among Americans who abuse prescription painkillers, a new study finds. OxyContin and Percocet are brand names for drugs containing oxycodone. ...
Tags: oxycodone, abuse prescription painkillers, OxyContin, Percocet
Abuse of narcotic painkillers and other prescription drugs is a growing problem in the United States, and a leading doctors' group is urging members to exercise tighter control on the medications. The American College of Physicians (ACP) ...
Close to 16 percent, or 37 million of adults agree that paying more for branded prescription medications rather than getting generic products, according to Kantar Media's 2013 OTC/DTC Study. Forty-five percent or 106 million adults ...
Tags: Branded Medications, Generic Products, Adults Preferences OTC/DTC
Wolters Kluwer Health, a provider of information for healthcare professionals and students, has announced that its Medi-Span Controlled Substances Drug File has been selected by Health Market Science (HMS) for integration with its ...
Tags: Health Market, Medicine
QRxPharma, an Australian-based commercial-stage specialty pharmaceutical company, has resubmitted its MOXDUO new drug application (NDA). At a meeting in early October 2013, the US Food and Drug Administration (FDA) provided QRxPharma with ...
Tags: QRxPharma, Drug Application
US-based BioMarin Pharmaceutical has announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the US Food and Drug Administration (FDA) voted in favor of approval of Vimizim for the treatment of Morquio A ...
The US Food and Drug Administration (FDA) has accepted for review US-based biopharmaceutical firm NPS Pharmaceuticals' supplemental new drug application (sNDA) for Gattex (teduglutide [rDNA origin]) for injection. In the US, Gattex is ...
Tags: FDA, biopharmaceutical
Health insurance has long been one of the biggest obstacles to early retirement, but the Affordable Care Act may solve that, U.S. retirement experts say. The Employee Benefit Research Institute says only 18 percent of current ...
Tags: health insurance, scary, retiree
Almost 80 percent of U.S. Medicare beneficiaries age 65 and older don't know the last day for open enrollment to make changes in their insurance plan is Dec. 7. Medicare beneficiaries have from Oct. 15 to Dec. 7 to make changes in their ...
Tags: medicare, beneficiaries, last day, insurance
Lundbeck, a Denmark-based pharmaceutical company, has obtained the US Food and Drug Administration (FDA) approval for its SABRIL (vigabatrin), an adjunctive treatment option for children 10 and older with refractory complex partial ...
Amarin, a biopharmaceutical company, has announced the outcome of the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee for the use of Vascepa (icosapent ethyl) capsules in the treatment of high ...
AMAG Pharmaceuticals has received a notice of three-month extension from the US Food and Drug Administration (FDA) for a supplemental new drug application (sNDA) for Feraheme (ferumoxytol) injection to be used for intravenous (IV) therapy. ...
Tags: AMAG Pharma, Intravenous Use